A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS Our vision is to enrich the world through the best of nutrition. We are a leading formulator, manufacturer and marketer of nutritional supplements. Our comprehensive strategic partnerships with our customers allow us to offer a wide range of innovative nutritional products and services to such customers including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review, and international product registration assistance. As our primary business activity, we provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal and other nutritional supplements, as well as other health care products, to consumers both within and outside the U.S.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 135M | 130M | 114M | 154M | 171M | 179M |
| Net Income | -12M | -14M | -7.2M | 2.5M | 11M | 11M |
| EPS | $-2.05 | $-2.28 | $-1.23 | $0.43 | $1.74 | $1.69 |
| Free Cash Flow | -5.2M | 2.3M | -4.5M | -6.5M | -15M | 16M |
| ROIC | -6.5% | -17.6% | -7.9% | 4.7% | 19.5% | 76.8% |
| Gross Margin | 9.1% | 7.2% | 6.0% | 11.8% | 17.8% | 17.1% |
| Debt/Equity | 0.14 | 0.14 | 0.12 | 0.11 | 0.11 | 0.00 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -5.6M | -8.7M | -8.5M | 4.7M | 14M | 14M |
| Operating Margin | -4.1% | -6.7% | -7.5% | 3.1% | 8.0% | 7.7% |
| ROE | -18.3% | -18.0% | -8.7% | 2.8% | 12.1% | 13.4% |
| Shares Outstanding | 6M | 6M | 6M | 6M | 6M | 6M |
NATURAL ALTERNATIVES INTERNATIONAL INC passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 15.1% with a gross margin of 12.0%. Total shareholder yield (buybacks) is 1.0%. At current prices, the estimated annualized return to fair value is +21.8%.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a 5-year average return on invested capital (ROIC) of 15.1%. This indicates strong capital allocation and a potential competitive advantage.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a market capitalization of $17M. It is classified as a small-cap stock.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 1.03%.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) operates in the Medicinal Chemicals & Botanical Products industry, within the Healthcare sector.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported annual revenue of $130 million in its most recent fiscal year, based on SEC EDGAR filings.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a net profit margin of -10.5%. The company is currently unprofitable.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) generated $2 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a debt-to-equity ratio of 0.14. This indicates a conservatively financed balance sheet.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported earnings per share (EPS) of $-2.28 in its most recent fiscal year.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a return on equity (ROE) of -18.0%. A negative ROE may indicate losses or negative equity.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a 5-year average gross margin of 12.0%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 15 years of financial data for NATURAL ALTERNATIVES INTERNATIONAL INC (NAII), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) has a book value per share of $11.49, based on its most recent annual SEC filing.